Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A device combining a virtual reality (VR) headset with hypnotic scenarios may represent an effective tool to reduce anxiety and opposition during hygiene care in patients with neurocognitive disorders presenting with behavioral and psychological symptoms.
The primary objective of this project is to assess the feasibility and effectiveness of VR headsets with hypnotic scenarios compared with standard care in patients with ADRD presenting behavioral disturbances during hygiene care.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| controlled trial | Active Comparator |
| |
| VR headset | Experimental | a virtual reality (VR) headset with hypnotic scenarios |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VR headset | Device | VR headset enabling the management of hypnotic scenarios. The headset will project immersive 3D images and deliver a hypnotic narrative, thus combining VR and hypnosis-based techniques. This intervention will be applied during hygiene and toileting care and compared to standard behavioral management traditionally used in the structures. |
| Measure | Description | Time Frame |
|---|---|---|
| Effectiveness of VR headsets | Effectiveness of VR headsets delivering hypnotic scenarios versus standard cares in older adults with ADRD and behavioral disturbances (opposition or agitation), with the aim of reducing apprehension, pain, anxiety, and resistance during hygiene and toileting care. Evaluation with EPADE sclae | up to 5 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| decrease number of patients with behavioral and psychological symptoms in VR headset group | up to 5 weeks | |
| reduced number of psychotropic drug per patient use in VR headset group | reduced number of psychotropic drug per patient use in VR headset group |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Frédéric Bloch, MD | Contact | 33+3 22 08 80 51 | Bloch.frederic@chu-amiens.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Amiens University Hospital | Recruiting | Amiens | 80054 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| standard cares | Other | standard cares |
|
| up to 5 weeks |
| Number of patients with improve quality of life in VH headset group | Number of patients with improve quality of life in VH headset group | up to 5 weeks |
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D001523 | Mental Disorders |
| ID | Term |
|---|---|
| D003704 | Dementia |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D024801 | Tauopathies |
| D019636 | Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
Not provided
Not provided